Skip to content
Open access

Smilax glabra flavonoids ameliorate non-alcoholic steatohepatitis by regulating PKM2-dependent glycolysis and suppressing AIM2 inflammasome activation

Sep 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 76 references
Medicine

TL;DR

SGF effectively ameliorates HFD-induced NASH by reversing metabolic disturbance, relieving oxidative stress and liver injury, and suppressing PKM2-dependent glycolysis and AIM2 inflammasome activation.

Abstract

Background Nonalcoholic steatohepatitis (NASH) is a prevalent chronic liver disease characterized by hepatic steatosis, persistent inflammation and progressive liver damage. Smilax glabra flavonoids (SGF), the major bioactive constituents of Smilax glabra Roxb., exhibit potent antioxidant and anti-inflammatory activities. Nevertheless, their therapeutic role and molecular basis in NASH remain elusive. Methods This study aimed to investigate the protective effects of SGF against high-fat diet (HFD)-induced NASH in mice, with emphasis on PKM2-mediated glycolysis and AIM2 inflammasome activation. C57BL/6J mice were fed an HFD for 20 weeks to establish a NASH model and concurrently treated with SGF (30 or 90 mg/kg/day) or empagliflozin (EMPA). Comprehensive assessments, including biochemical detection, histological staining and molecular biological verification, were performed. In vitro, FFA-challenged AML-12 hepatocytes and LPS-stimulated RAW264.7 macrophages were adopted. siRNA-mediated knockdown, lentiviral overexpression, and cell co-culture models were further applied to validate the underlying mechanisms. Results SGF markedly attenuated HFD-induced obesity, dyslipidemia, hepatic steatosis, fibrosis and hepatocellular damage, mitigated hepatic oxidative stress and restored mitochondrial structure integrity. Mechanistically, SGF restrained glycolytic metabolism by downregulating the expression of HK2, p-PKM2, and LDHA and by reducing pyruvate and lactate production. Besides, SGF mitigated AIM2 inflammasome activation and decreased the levels of AIM2, ASC, caspase-1, and IL-1β. Mechanistic validation confirmed that PKM2 was abundantly expressed in macrophages, and PKM2 overexpression partially abrogated the inhibitory effects of SGF on glycolysis and AIM2 inflammasome signaling. Co-culture assays further demonstrated that PKM2 overexpression in RAW264.7 macrophages exacerbated lipid deposition, oxidative stress, glycolysis, and AIM2 inflammasome activation in AML-12 hepatocytes, thereby counteracting the hepatoprotective effects of SGF. Conclusion SGF effectively ameliorates HFD-induced NASH by reversing metabolic disturbance, relieving oxidative stress and liver injury, and suppressing PKM2-dependent glycolysis and AIM2 inflammasome activation. Macrophage PKM2 acts as a key mediator of pathogenic macrophage-hepatocyte crosstalk, which is critical for the hepatoprotective effects of SGF against NASH. Overall, our study findings highlight SGF as a promising therapeutic option for this specific population.

Read PDF

Similar papers

Open access 2026

Saikosaponin D Ameliorates Non-alcoholic Steatohepatitis by Inhibiting STING-Mediated Macrophage M1 Polarization in Mice.

Saikosaponin D ameliorates NASH by inhibiting the STING-TBK1-IRF3/NF-κB axis in macrophages and promoting M1-to-M2 polarization, identifying SSd as a promising immunomodulatory therapy for NASH.

Wen-Jie Zhang, Yao-Hui Yin, Si-Qi Cheng et al. · 0 citations
Open access Aug 2026

Shenling Baizhu powder alleviates non-alcoholic steatohepatitis by reducing PPARα-mediated NLRP3 inflammasome activation

The findings indicate that SL mitigates NASH by activating the PPAR pathway and suppressing the ER stress-triggered UPR, thereby inhibiting NLRP3 inflammasome activation and inhibiting NLRP3 inflammasome activation.

Si-Yuan Huang, Yuan-Jun Deng, Da-Jin Pi et al. · 0 citations
Open access Oct 2026

Xiaochaihutang Extract Ameliorates Metabolic Dysfunction-Associated Steatohepatitis in Mice and Modulates the Gut–Liver Axis

Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease characterized by lipid metabolism dysregulation, insulin resistance, inflammation, and potential progression to severe liver conditions. Xiaochaihutang (XCHT), a traditional Chinese medicine, has been explored for its therapeutic pot...

Jia-Jia Yu, Zhi-Yuan Liu, Yan-Ping Li et al. · 0 citations
Open access Sep 2026

Panacis Quinquefolii Radix glucan ameliorates liver fibrosis by modulating macrophage polarization and suppressing inflammation via the TLR4/MyD88/NF-κB signaling pathway

Findings highlight XYS1-1, as a promising candidate for functional foods targeting liver health, while expanding insights into natural polysaccharide-based strategies against liver fibrosis, as a promising candidate for functional foods targeting liver health.

Ming-Hui Zhang, Qian-Xiao Chen, Ming-Xue Cha et al. · 0 citations
Open access Sep 2026

Hepatoprotective action of Dendrobium officinale polysaccharide against MAFLD: modulation of gut microbiota-metabolite cascade controls TLR4/NF-κB inflammatory response

DOP markedly alleviated hepatic lipid accumulation, restored liver function abnormalities and mitigated hepatic pathological damage, and confers protective effects against MAFLD through remodeling gut microbiota and intestinal metabolites, preserving intestinal-barrier integrity, and inhibiting LPS-provoked hepatic TLR...

Yu-Mei Xu, Yan-Mei Zhang, Shu-Qi Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.